申请人:THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human servic
公开号:US20210139440A1
公开(公告)日:2021-05-13
This disclosure concerns fatty acid derivatives, pharmaceutical compositions comprising the fatty acid derivatives, and methods of using the fatty acid derivatives, for example, to treat inflammation, chronic itch, chronic pain, an autoimmune disorder, atherosclerosis, a skin disorder, arthritis, a neurodegenerative disorder, or a psychiatric disorder in a subject. In some embodiments, the fatty acid derivative is a compound, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, having a structure according to:
wherein X is from 1-16 carbons in length, Z is aliphatic from 1-16 carbons in length, or is not present, Y is selected from:
R
1
, R
2
, and R
3
are independently hydrogen or lower alkyl, R
4
is lower alkyl, hydroxyl, carboxyl, or amine, R
5
is hydrogen, lower alkyl, or halide, R
6
is hydroxyl or substituted thiol, and each R
7
is independently hydrogen or fluoride or is not present and the adjacent carbons form alkyne.